Characteristics IER3 | No. of cases (%) | IER3 expreesion | |||
---|---|---|---|---|---|
Low or none, no. cases | High, no. cases | Statistic (c2) | p value | ||
Age | |||||
  < 50 | 37 (41.1) | 14 | 23 | 1.509 | 0.219 |
  ≥ 50 | 53 (58.9) | 27 | 26 | ||
Gender | |||||
 Male | 80 (88.9) | 37 | 43 | 0.14 | 0.708 |
 Female | 10 (11.1) | 4 | 6 | ||
HBsAg | |||||
 Positive | 70 (77.8) | 29 | 41 | 2.84 | 0.092 |
 Negative | 19 (21.1) | 12 | 7 | ||
HBcAb | |||||
 Positive | 80 (88.9) | 35 | 45 | 1.985 | 0.159 |
 Negative | 7 (7.8) | 5 | 2 | ||
HCV | |||||
 Positive | 1 (1.1) | 0 | 1 | 0.861 | 0.353 |
 Negative | 86 (95.6) | 40 | 46 | ||
Liver cirrhosis | |||||
 Yes | 80 (88.9) | 38 | 42 | 0.09 | 0.419 |
 No | 9 (10.0) | 3 | 6 | ||
Total bilirubin (mmol/L) | |||||
  < 21 | 75 (83.3) | 36 | 39 | 0.717 | 0.397 |
  ≥ 21 | 14 (15.6) | 5 | 9 | ||
ALT (U/L) | Â | Â | Â | Â | Â |
  < 60 | 70 (77.8) | 29 | 41 | 2.84 | 0.092 |
  ≥ 60 | 19 (21.1) | 12 | 7 | ||
GGT (U/L) | |||||
  < 40 | 30 (33.3) | 9 | 21 | 4.702 | 0.030 |
  ≥ 40 | 59 (65.6) | 32 | 27 | ||
AFP (ng/L) | |||||
  < 20 | 36 (40.0) | 17 | 19 | 0.067 | 0.795 |
  ≥ 20 | 54 (60.0) | 24 | 30 | ||
Cirrhotic nodules | |||||
 Single | 10 (11.1) | 5 | 5 | 0.653 | 0.765 |
 Multiple | 80 (88.9) | 36 | 44 | ||
Vascular invasion | |||||
 Yes | 21 (23.3) | 12 | 9 | 1.545 | 0.214 |
 No | 58 (64.4) | 24 | 34 | ||
Tumor number | |||||
 Single | 79 (87.8) | 36 | 43 | 0 | 0.994 |
 Multiple | 11 (12.2) | 5 | 6 | ||
Tumor size | |||||
  < 5 cm | 55 (61.1) | 16 | 39 | 15.458 |  < 0.001 |
  ≥ 5 cm | 35 (38.9) | 25 | 10 | ||
Recrudescence | |||||
 Yes | 49 (54.4) | 27 | 22 | 3.952 | 0.047 |
 No | 41 (45.6) | 14 | 27 | ||
AJCC TNM stage | |||||
 I stage | 58 (64.4) | 24 | 34 | 1.392 | 0.499 |
 II stage | 29 (32.2) | 15 | 14 | ||
 III stage | 3 (33.3) | 2 | 1 |